Drug
Modafinil Placebo
Modafinil Placebo is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 4 completed trials
Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
50%(2 trials)
Phase Distribution
Ph phase_1
2
40%
Ph phase_3
1
20%
Ph phase_2
2
40%
Phase Distribution
2
Early Stage
2
Mid Stage
1
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)
Phase 3Large-scale testing
1(20.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
4 of 4 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(1)
Completed(4)
Detailed Status
Completed4
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 12 (40.0%)
Phase 22 (40.0%)
Phase 31 (20.0%)
Trials by Status
completed480%
active_not_recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
active_not_recruitingphase_2
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
NCT06404099
completedphase_2
RECOVER-SLEEP: Platform Protocol
NCT06404086
completedphase_1
A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)
NCT06619665
completedphase_1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
NCT03522506
completedphase_3
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
NCT00066170
Clinical Trials (5)
Showing 5 of 5 trials
NCT06404099Phase 2
RECOVER-SLEEP: Platform Protocol, Appendix_A (Hypersomnia)
NCT06404086Phase 2
RECOVER-SLEEP: Platform Protocol
NCT06619665Phase 1
A Study of MK-6552 in Sleep Deprived Healthy Participants (MK-6552-003)
NCT03522506Phase 1
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
NCT00066170Phase 3
Trial Comparing Effects of Xyrem Taken Orally and Modafinil With Placebo in Treating Daytime Sleepiness in Narcolepsy
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5